Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Mar 2023 for Bioventus Inc.. Read the official filing
Filing timeline
BuySaleKenneth Michael Reali
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-4.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Kenneth Michael Reali: trading record in brief
Kenneth Michael Reali (chief executive) discloses dealings in Bioventus Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 9 September 2021 to 14 March 2023.
Purchases make up the whole of the open-market record (1 purchase, €23k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise.
On 16 March 2023 came the latest disclosure, an option exercise in Bioventus Inc. The last insider purchase was made public on 10 September 2021, 1,864 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kenneth Michael Reali
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
28,721 sharesClass A Common StockSEC:0000899243-23-008792:0
1,800 shares@ US$14.81100.0% of flowClass A Common StockSEC:0000899243-21-035518:0
Canonical exit: 8 Dec 2021 (T+90)
2 of 2 declarations
